English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/134325
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells

AuthorsCitterio, Carmen; Menacho-Márquez, Mauricio ; García-Escudero, Ramón; Larive, Romain M.; Barreiro, Olga; Sánchez-Madrid, Francisco; Paramio, Jesús M.; Bustelo, Xosé R.
Issue Date2012
PublisherAmerican Association for the Advancement of Science
CitationScience Signaling 5(244): ra71 (2012)
AbstractThe guanosine triphosphatases of the Rho and Rac subfamilies regulate protumorigenic pathways and are activated by guanine nucleotide exchange factors (Rho GEFs), which could be potential targets for anticancer therapies. We report that two Rho GEFs, Vav2 and Vav3, play synergistic roles in breast cancer by sustaining tumor growth, neoangiogenesis, andmany of the steps involved in lung-specific metastasis. The involvement of Vav proteins in these processes did not correlate with Rac1 and RhoA activity or cell migration, implying the presence of additional biological programs. Microarray analyses revealed that Vav2 and Vav3 controlled a vast transcriptional program in breast cancer cells through mechanisms that were shared between the two proteins, isoform-specific or synergistic. Furthermore, the abundance of Vavregulated transcripts wasmodulated by Rac1-dependent and Rac1-independent pathways. This transcriptome encoded therapeutically targetable proteins that played nonredundant roles in primary tumorigenesis and lung-specific metastasis, such as integrin-linked kinase (Ilk), the transforming growth factor-β family ligand inhibin βA, cyclooxygenase-2, and the epithelial cell adhesionmolecule Tacstd2. It also contained gene signatures that predicted disease outcome in breast cancer patients. These results identify possible targets for treating breast cancer and lung metastases and provide a potential diagnostic tool for clinical use.
Publisher version (URL)http://dx.doi.org/10.1126/scisignal.2002962
URIhttp://hdl.handle.net/10261/134325
DOI10.1126/scisignal.2002962
Identifiersdoi: 10.1126/scisignal.2002962
issn: 1945-0877
e-issn: 1937-9145
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
Vav2-3.pdf40,78 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.